An	O
oncogenic	O
MYB	S-GENE
feedback	O
loop	O
drives	O
alternate	O
cell	O
fates	O
in	O
adenoid	O
cystic	O
carcinoma	O
.	O


Translocation	O
events	O
are	O
frequent	O
in	O
cancer	O
and	O
may	O
create	O
chimeric	O
fusions	O
or	O
'	O
regulatory	O
rearrangements	O
'	O
that	O
drive	O
oncogene	O
overexpression	O
.	O


Here	O
we	O
identify	O
super	O
-	O
enhancer	O
translocations	O
that	O
drive	O
overexpression	O
of	O
the	O
oncogenic	O
transcription	O
factor	O
MYB	S-GENE
as	O
a	O
recurrent	O
theme	O
in	O
adenoid	O
cystic	O
carcinoma	O
(	O
ACC	O
)	O
.	O


Whole	O
-	O
genome	O
sequencing	O
data	O
and	O
chromatin	O
maps	O
highlight	O
distinct	O
chromosomal	O
rearrangements	O
that	O
juxtapose	O
super	O
-	O
enhancers	O
to	O
the	O
MYB	S-GENE
locus	O
.	O


Chromosome	O
conformation	O
capture	O
confirms	O
that	O
the	O
translocated	O
enhancers	O
interact	O
with	O
the	O
MYB	S-GENE
promoter	O
.	O


Remarkably	O
,	O
MYB	S-GENE
protein	O
binds	O
to	O
the	O
translocated	O
enhancers	O
,	O
creating	O
a	O
positive	O
feedback	O
loop	O
that	O
sustains	O
its	O
expression	O
.	O
MYB	S-GENE
also	O
binds	O
enhancers	O
that	O
drive	O
different	O
regulatory	O
programs	O
in	O
alternate	O
cell	O
lineages	O
in	O
ACC	O
,	O
cooperating	O
with	O
TP63	S-GENE
in	O
myoepithelial	O
cells	O
and	O
a	O
Notch	O
program	O
in	O
luminal	O
epithelial	O
cells	O
.	O


Bromodomain	O
inhibitors	O
slow	O
tumor	O
growth	O
in	O
ACC	O
primagraft	O
models	O
in	O
vivo	O
.	O


Thus	O
,	O
our	O
study	O
identifies	O
super	O
-	O
enhancer	O
translocations	O
that	O
drive	O
MYB	S-GENE
expression	O
and	O
provides	O
insight	O
into	O
downstream	O
MYB	S-GENE
functions	O
in	O
alternate	O
ACC	O
lineages	O
.	O
